|
AMMECR1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.620800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.985600E-01 |
| Normal-vs-Stage2 |
3.498800E-01 |
| Normal-vs-Stage3 |
7.931700E-02 |
| Normal-vs-Stage4 |
1.385990E-02 |
| Stage1-vs-Stage2 |
1.631590E-01 |
| Stage1-vs-Stage3 |
1.016110E-02 |
| Stage1-vs-Stage4 |
7.593800E-04 |
| Stage2-vs-Stage3 |
6.516400E-01 |
| Stage2-vs-Stage4 |
3.423600E-01 |
| Stage3-vs-Stage4 |
4.755200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.289400E-01 |
| Normal-vs-AfricanAmerican |
9.747200E-01 |
| Normal-vs-Asian |
1.749960E-02 |
| Caucasian-vs-AfricanAmerican |
4.063600E-01 |
| Caucasian-vs-Asian |
1.983690E-02 |
| AfricanAmerican-vs-Asian |
9.565600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.281600E-02 |
| Normal-vs-Female |
3.421000E-01 |
| Male-vs-Female |
4.561800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.689420E-01 |
| Normal-vs-Age(41-60Yrs) |
7.082000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.639200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.701800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.860000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.877800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.725800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.661200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.601800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.480400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.483600E-02 |
| Normal-vs-Grade 2 |
4.302400E-01 |
| Normal-vs-Grade 3 |
8.763600E-02 |
| Normal-vs-Grade 4 |
2.236500E-03 |
| Grade 1-vs-Grade 2 |
1.701010E-01 |
| Grade 1-vs-Grade 3 |
5.661900E-03 |
| Grade 1-vs-Grade 4 |
3.371600E-04 |
| Grade 2-vs-Grade 3 |
1.899430E-03 |
| Grade 2-vs-Grade 4 |
3.86490000000572E-05 |
| Grade 3-vs-Grade 4 |
9.269900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.252100E-02 |
| Normal-vs-ccB subtype |
1.183810E-02 |
| ccA subtype-vs-ccB subtype |
6.76300000002072E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.053400E-01 |
| Normal-vs-N1 |
4.158000E-01 |
| N0-vs-N1 |
7.732800E-01 |
|
|
